Aerovate Therapeutics Statistics

Total Valuation

AVTE has a market cap or net worth of $591.43 million. The enterprise value is $492.87 million.

Market Cap	591.43M
Enterprise Value	492.87M

Important Dates

The last earnings date was Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

AVTE has 28.81 million shares outstanding. The number of shares has increased by 12.18% in one year.

Shares Outstanding	28.81M
Shares Change (YoY)	+12.18%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	104.40%
Float	11.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.51
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.01.

Current Ratio	6.65
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -70.20% and return on invested capital (ROIC) is -96.41%.

Return on Equity (ROE)	-70.20%
Return on Assets (ROA)	-61.90%
Return on Capital (ROIC)	-96.41%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTE has paid $56,000 in taxes.

Income Tax	56,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.70% in the last 52 weeks. The beta is 1.39, so AVTE's price volatility has been higher than the market average.

Beta (1Y)	1.39
52-Week Price Change	+5.70%
50-Day Moving Average	24.08
200-Day Moving Average	18.28
Relative Strength Index (RSI)	44.86
Average Volume (30 Days)	161,195

Short Selling Information

The latest short interest is 1.88 million, so 6.53% of the outstanding shares have been sold short.

Short Interest	1.88M
Short Previous Month	1.25M
Short % of Shares Out	6.53%
Short % of Float	16.96%
Short Ratio (days to cover)	11.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-88.39M
Pretax Income	-82.13M
Net Income	-82.19M
EBITDA	-82.03M
EBIT	-82.13M
Earnings Per Share (EPS)	-$3.04

Full Income Statement

Balance Sheet

The company has $99.33 million in cash and $774,000 in debt, giving a net cash position of $98.56 million or $3.42 per share.

Cash & Cash Equivalents	99.33M
Total Debt	774,000
Net Cash	98.56M
Net Cash Per Share	$3.42
Equity / Book Value	90.90M
Book Value Per Share	3.16
Working Capital	87.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.03 million and capital expenditures -$126,000, giving a free cash flow of -$69.15 million.

Operating Cash Flow	-69.03M
Capital Expenditures	-126,000
Free Cash Flow	-69.15M
FCF Per Share	-$2.49

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVTE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.18%
Shareholder Yield	-12.18%
Earnings Yield	-13.90%
FCF Yield	-11.69%

Analyst Forecast

The average price target for AVTE is $47.00, which is 128.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$47.00
Price Target Difference	128.49%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	4.10%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2